ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

RayzeBio at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

RayzeBio at ESMO 2026 in Madrid: Booth 1004.

OrganizationESMO 2026 Attendance
BiotechExhibitor
Radiopharmaceutical developer of actinium-225-based cancer therapies, owned by Bristol Myers Squibb.
Booth
Exhibiting at Booth 1004

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at RayzeBio

Tell us what you sell and we’ll find the people at RayzeBio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction